Dissecting the mechanism of RIPK1 kinase-dependent cell death in control of Yersinia infection
剖析 RIPK1 激酶依赖性细胞死亡控制耶尔森菌感染的机制
基本信息
- 批准号:9285729
- 负责人:
- 金额:$ 20.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-06 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlpha CellAnti-Bacterial AgentsApoptosisBacterial InfectionsBone MarrowCASP8 geneCell DeathCell Death InductionCellsCessation of lifeCharacteristicsComplexCoupledCytotoxic T-LymphocytesDataDefectDiseaseEnsureEnzymesFoundationsFutureGastroenteritisGoalsHematopoieticHost DefenseImmuneImmune responseImmune signalingImmunityInfectionInflammation MediatorsInflammatoryInflammatory ResponseInjectableInnate Immune ResponseInstructionInterferon Type IIInterleukin-12KnowledgeLeadLightLymphocyteMAP Kinase GeneMediatingMolecularMusPasteurella pseudotuberculosisPathogenicityPathologicPathway interactionsPhosphotransferasesPlaguePlayPopulationProductionProtein KinasePublishingRIPK1 geneRoleSignal PathwaySignal TransductionStimulusT cell responseTNF geneTestingTimeTissuesToll-like receptorsVirulenceVirulence FactorsYersiniaYersinia infectionsYersinia pestisadaptive immune responseantimicrobialbasecell typecytokinecytotoxicitydefined contributionextracellularin vivoinsightmacrophagemicrobialmonocytemutantnoveloral infectionpathogenpublic health relevancereceptorresponse
项目摘要
Project Summary
Immune defense against bacterial infection requires activation of conserved signaling pathways that upregulate
production of inflammatory mediators to clear infection. Many pathogens, including the pathogenic Yersinia
inhibit these signaling pathways in order to evade host immune defenses. Yersinia injects a virulence factor,
YopJ, which blocks NF-ΚB and MAPK signaling. How immune defense is mediated against pathogens that
block immune signaling pathways remains poorly understood. NF-κB blockade in macrophages exposed to
bacterial PAMPs leads to cell death with characteristics of apoptosis, yet this death has pro-inflammatory
consequences. Notably, increasing cytotoxicity of Y. pseudotuberculosis or Y. pestis results in decreased
bacterial virulence, suggesting that induction of cell death in response to Yersinia serves as a host immune
protective mechanism. Our central hypothesis is that cell death triggered in response to Yersinia blockade of
NF-κB and MAPK releases pro-inflammatory signals that alert uninfected neighboring cells to the presence of
infection. However, the cellular and molecular basis for this response remains unclear. Our recently published
and preliminary data demonstrate that RIPK1 kinase activity is required for Yersinia-induced cell death.
Moreover, RIPK1 kinase activity contributes to control of Yersinia infection and to inflammatory cytokine
production in vivo. Nevertheless, how RIPK1 kinase activity and cell death are coupled to inflammatory
responses and host defense against bacterial infection is not known. This is an important problem as this
pathway likely responds to many pathogens that block critical innate immune signaling pathways and in the
context of pathological stimuli that lead to RIPK1-induced cell death. We propose two Specific Aims to address
this important gap in our knowledge. First we will define the cellular population that requires RIPK1 kinase
activity, and determine whether RIPK1 functions in a cell-intrinsic or extrinsic manner to mediate anti-bacterial
immune defense. Second, we will will determine the contribution of RIPK1 to downstream pathogen-specific
immune responses and will dissect whether RIPK1 functions to control bacterial dissemination or replication.
项目摘要
免疫防御细菌感染需要激活更新的配置信号通路
产生炎症介质以清除感染。许多病原体,包括病原耶尔森氏菌
抑制这些信号通路以逃避宿主免疫防御。 Yersinia注射病毒因子,
YOPJ,阻断NF-κB和MAPK信号传导。如何针对病原体介导免疫诱因
阻止免疫信号通路仍然了解不足。巨噬细胞中的NF-κB封锁
细菌症状症状导致细胞死亡,并具有细胞凋亡的特征,但这种死亡具有促炎症
结果。值得注意的是,Y. pseudotuberculculosis或Y. Pestis的细胞毒性增加导致下降
细菌病毒,表明对耶尔森氏菌的诱导诱导可作为宿主免疫
保护机制。我们的中心假设是,响应于Yersinia封锁的细胞死亡
NF-κB和MAPK释放促炎性信号,使未感染的相邻细胞警告出现
感染。但是,该反应的细胞和分子基础尚不清楚。我们最近出版的
初步数据表明,耶尔森尼亚诱导的细胞死亡需要RIPK1激酶活性。
此外,RIPK1激酶活性有助于控制耶尔森氏菌感染和炎性细胞因子
体内生产。然而,RIPK1激酶活性和细胞死亡如何与炎症耦合
反应和宿主防御细菌感染尚不清楚。这是一个重要的问题
途径可能会响应许多阻断关键先天免疫信号通路和在
导致RIPK1诱导细胞死亡的病理刺激的背景。我们提出了两个特定的目的来解决
我们知识上的这一重要差距。首先,我们将定义需要RIPK1激酶的细胞群
活性,并确定RIPK1是否以细胞中的或外在的方式起作用以介导抗细菌
免疫防御。其次,我们将确定RIPK1对下游病原体特异性的贡献
免疫反应,并将剖析RIPK1是否功能控制细菌传播或复制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IGOR E BRODSKY其他文献
IGOR E BRODSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IGOR E BRODSKY', 18)}}的其他基金
Defining mechanisms of Casp1/11-independent death triggered by clinical Salmonella Enteritidis
临床肠炎沙门氏菌触发的 Casp1/11 独立死亡的定义机制
- 批准号:
10452195 - 财政年份:2022
- 资助金额:
$ 20.86万 - 项目类别:
Defining mechanisms of Casp1/11-independent death triggered by clinical Salmonella Enteritidis
临床肠炎沙门氏菌触发的 Casp1/11 独立死亡的定义机制
- 批准号:
10580079 - 财政年份:2022
- 资助金额:
$ 20.86万 - 项目类别:
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense
明确RIPK1诱导细胞死亡在抗菌免疫防御中的机制和功能
- 批准号:
10329911 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense
明确RIPK1诱导细胞死亡在抗菌免疫防御中的机制和功能
- 批准号:
10092916 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defense
明确RIPK1诱导细胞死亡在抗菌免疫防御中的机制和功能
- 批准号:
10557104 - 财政年份:2019
- 资助金额:
$ 20.86万 - 项目类别:
Defining the non-apoptotic role of Caspase-8 activity in anti-bacterial immune defense
定义 Caspase-8 活性在抗菌免疫防御中的非凋亡作用
- 批准号:
9229681 - 财政年份:2017
- 资助金额:
$ 20.86万 - 项目类别:
相似国自然基金
Galectin-3调控PD-L1在原发性肝细胞癌免疫治疗和预后中的作用及机制
- 批准号:82304216
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FOXO3 m6A甲基化修饰诱导滋养细胞衰老效应在补肾法治疗自然流产中的机制研究
- 批准号:82305286
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
神经母细胞瘤EDF1促进神经节苷脂贮积诱导CD8+T细胞耗竭的机制研究
- 批准号:82373421
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肝细胞CREG1抑制其富含miR-34的外泌体分泌并减少巨噬细胞的活化,进而延缓肝纤维化的进展
- 批准号:82300713
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
化学小分子激活YAP诱导染色质可塑性促进心脏祖细胞重编程的表观遗传机制研究
- 批准号:82304478
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx
影响肺炎链球菌从鼻咽部侵入后中耳早期清除的宿主因素
- 批准号:
10358434 - 财政年份:2022
- 资助金额:
$ 20.86万 - 项目类别:
S1PR1 Mislocalization in Lung Endothelium Regulates Innate Immune Function and Mediates Inflammatory Lung Injury
S1PR1 在肺内皮细胞中的错误定位调节先天免疫功能并介导炎症性肺损伤
- 批准号:
10494616 - 财政年份:2022
- 资助金额:
$ 20.86万 - 项目类别:
Role of IFNs and IFNGR in susceptibility to bacteria in Down syndrome
IFN 和 IFNGR 在唐氏综合症细菌易感性中的作用
- 批准号:
10356944 - 财政年份:2021
- 资助金额:
$ 20.86万 - 项目类别:
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
以非洲为中心的 TP53 变异在非裔美国人中较高的幽门螺杆菌患病率中的作用
- 批准号:
10541244 - 财政年份:2021
- 资助金额:
$ 20.86万 - 项目类别:
The First Pomegranate Seed Oil-Containing Medical Food for Gut and Immune Health
第一种含有石榴籽油的用于肠道和免疫健康的医疗食品
- 批准号:
10010938 - 财政年份:2020
- 资助金额:
$ 20.86万 - 项目类别: